1	[	[	-LRB-	_	2	punct	_
2	USPRwire	usprwire	NNP	_	33	dep	_
3	,	,	,	_	2	punct	_
4	Mon	mon	NNP	_	5	nn	_
5	May	may	NNP	_	2	npadvmod	_
6	19	0	CD	_	5	num	_
7	2014	0	CD	_	5	num	_
8	]	]	-RRB-	_	2	punct	_
9	Although	although	IN	p2=NNP	12	mark	_
10	Mexico	mexico	NNP	_	12	nsubj	12:A0
11	has	have	VBZ	_	12	aux	_
12	made	make	VBN	pb=make.LV	33	advcl	33:AM-ADV
13	great	great	JJ	_	14	amod	_
14	efforts	effort	NNS	_	12	dobj	12:AM-PRR
15	to	to	TO	_	16	aux	_
16	improve	improve	VB	pb=improve.01	14	infmod	_
17	its	its	PRP$	_	19	poss	_
18	regulatory	regulatory	JJ	_	19	amod	_
19	framework	framework	NN	_	16	dobj	16:A1=PPT
20	and	and	CC	_	16	cc	_
21	create	create	VB	p2=VBP|pb=create.01	16	conj	_
22	a	a	DT	_	26	det	_
23	more	more	RBR	_	24	advmod	_
24	hospitable	hospitable	JJ	_	26	amod	_
25	business	business	NN	_	26	nn	_
26	environment	environment	NN	_	21	dobj	21:A1=PPT
27	to	to	TO	_	28	aux	_
28	entice	entice	VB	pb=entice.01	21	advcl	21:AM-PRP
29	pharmaceutical	pharmaceutical	JJ	p2=NN	30	amod	_
30	companies	company	NNS	_	28	dobj	28:A1=PPT
31	,	,	,	_	33	punct	_
32	it	it	PRP	_	33	nsubj	33:A1=PPT
33	is	be	VBZ	pb=be.01	0	root	_
34	still	still	RB	_	33	advmod	33:AM-TMP
35	hard	hard	JJ	p2=RB	33	acomp	33:A2=PRD
36	for	for	IN	_	40	mark	_
37	multinationals	multinational	NNS	_	40	nsubj	40:A0
38	to	to	TO	p2=IN	40	aux	_
39	fully	fully	RB	_	40	advmod	40:AM-EXT
40	materialise	materialise	VB	pb=materialise.01	33	advcl	_
41	their	their	PRP$	_	43	poss	_
42	commercial	commercial	JJ	_	43	amod	_
43	benefit	benefit	NN	_	40	dobj	40:A1
44	due	due	IN	p2=JJ	40	prep	40:AM-CAU
45	to	to	IN	_	44	pcomp	_
46	the	the	DT	_	49	det	_
47	significant	significant	JJ	_	49	amod	_
48	market	market	NN	_	49	nn	_
49	share	share	NN	_	44	pobj	_
50	of	of	IN	_	49	prep	_
51	generic	generic	JJ	_	52	amod	_
52	drugs	drug	NNS	_	50	pobj	_
53	.	.	.	_	33	punct	_

1	We	we	PRP	_	2	nsubj	2:A0=PAG
2	believe	believe	VBP	pb=believe.01	0	root	_
3	that	that	IN	_	7	complm	_
4	generic	generic	JJ	_	5	amod	_
5	drugs	drug	NNS	_	7	nsubj	7:A1=PPT
6	will	will	MD	_	7	aux	7:AM-MOD
7	be	be	VB	pb=be.01	2	ccomp	2:A1=PPT
8	a	a	DT	_	10	det	_
9	key	key	JJ	_	10	amod	_
10	element	element	NN	_	7	attr	7:A2=PRD
11	of	of	IN	_	10	prep	_
12	Mexico	mexico	NNP	_	15	poss	_
13	's	's	POS	_	12	possessive	_
14	healthcare	healthcare	NN	_	15	nn	_
15	modernisation	modernisation	NN	_	11	pobj	_
16	.	.	.	_	2	punct	_

1	They	they	PRP	_	2	nsubj	2:A1=PPT
2	are	be	VBP	pb=be.01	0	root	_
3	a	a	DT	_	6	det	_
4	very	very	RB	_	5	advmod	_
5	effective	effective	JJ	_	6	amod	_
6	way	way	NN	_	2	attr	2:A2=PRD;12:AM-MNR
7	in	in	IN	_	12	prep	12:R-AM-MNR
8	which	which	WDT	_	7	pobj	_
9	the	the	DT	_	10	det	_
10	government	government	NN	_	12	nsubj	12:A0=PAG;16:A0=PAG
11	can	can	MD	_	12	aux	12:AM-MOD
12	control	control	VB	pb=control.01	6	rcmod	_
13	public	public	JJ	_	14	amod	_
14	spending	spending	NN	_	12	dobj	12:A1=PPT
15	while	while	IN	_	16	mark	_
16	trying	try	VBG	pb=try.01	12	advcl	12:AM-TMP
17	to	to	TO	_	18	aux	_
18	increase	increase	VB	pb=increase.01	16	xcomp	16:A1=PPT
19	medicines	medicine	NNS	p2=JJ	20	nn	_
20	coverage	coverage	NN	_	18	dobj	18:A1=PPT
21	.	.	.	_	2	punct	_

1	However	however	RB	_	23	advmod	23:AM-DIS
2	,	,	,	_	23	punct	_
3	in	in	IN	_	23	prep	23:AM-CAU
4	the	the	DT	_	6	det	_
5	long	long	JJ	_	6	amod	_
6	term	term	NN	_	3	pobj	_
7	,	,	,	_	23	punct	_
8	Mexico	mexico	NNP	_	14	poss	_
9	's	's	POS	p2=VBZ	8	possessive	_
10	improving	improve	VBG	pb=improve.01	14	amod	_
11	private	private	JJ	_	14	amod	_
12	health	health	NN	_	13	nn	_
13	insurance	insurance	NN	_	14	nn	_
14	sector	sector	NN	_	23	nsubj	23:A0=PAG;10:A1=PPT
15	and	and	CC	_	14	cc	_
16	potentially	potentially	RB	_	17	advmod	_
17	significant	significant	JJ	_	18	amod	_
18	investment	investment	NN	_	14	conj	_
19	from	from	IN	_	18	prep	_
20	the	the	DT	_	21	det	_
21	government	government	NN	_	19	pobj	_
22	will	will	MD	_	23	aux	23:AM-MOD
23	boost	boost	VB	pb=boost.01	0	root	_
24	patented	patent	VBN	p2=JJ|pb=patent.01	26	amod	_
25	drug	drug	NN	_	26	nn	_
26	consumption	consumption	NN	_	23	dobj	23:A1=PPT;24:A1=PPT
27	in	in	IN	_	23	prep	23:AM-LOC
28	the	the	DT	_	29	det	_
29	country	country	NN	_	27	pobj	_
30	.	.	.	_	23	punct	_

1	*	*	NFP	_	2	punct	_
2	Pharmaceuticals	pharmaceutical	NNS	p2=NNPS	0	root	_
3	:	:	:	_	2	punct	_
4	MXN187.4bn	mxn187.4bn	NNP	p2=CD	2	appos	_
5	(	(	-LRB-	_	4	punct	_
6	USD	usd	NNP	p2=NN	7	nn	_
7	14.7bn	14.7bn	NNP	_	4	appos	_
8	)	)	-RRB-	_	4	punct	_
9	in	in	IN	_	2	prep	_
10	2013	0	CD	_	9	pobj	_
11	to	to	IN	p2=TO	2	prep	_
12	MXN204.1bn	mxn204.1bn	NNP	p2=CD	11	pobj	_
13	(	(	-LRB-	_	12	punct	_
14	USD	usd	NNP	p2=NN	15	nn	_
15	16.3bn	16.3bn	NNP	_	12	appos	_
16	)	)	-RRB-	_	12	punct	_
17	in	in	IN	_	2	prep	_
18	2014	0	CD	_	17	pobj	_
19	;	;	:	p2=,	2	punct	_
20	+8.9	+0	CD	p2=DT	21	num	_
21	%	%	NN	_	2	appos	_
22	in	in	IN	_	21	prep	_
23	local	local	JJ	_	25	amod	_
24	currency	currency	NN	_	25	nn	_
25	terms	term	NNS	_	22	pobj	_
26	and	and	CC	_	21	cc	_
27	+10.8	+0	CD	p2=NN	28	num	_
28	%	%	NN	_	21	conj	_
29	in	in	IN	_	28	prep	_
30	US	us	NNP	_	32	nn	_
31	dollar	dollar	NN	_	32	nn	_
32	terms	term	NNS	_	29	pobj	_
33	.	.	.	_	2	punct	_

1	Forecast	forecast	NNP	_	2	nsubj	2:A1=PPT
2	decreased	decrease	VBD	pb=decrease.01	0	root	_
3	from	from	IN	_	2	prep	2:A3=DIR
4	Q214	q214	NNP	_	3	pobj	_
5	due	due	IN	p2=JJ	2	prep	2:AM-CAU
6	to	to	IN	_	5	pcomp	_
7	increasing	increase	VBG	pb=increase.01	5	pcomp	_
8	generic	generic	JJ	_	9	amod	_
9	competition	competition	NN	_	7	dobj	7:A1=PPT
10	.	.	.	_	2	punct	_

1	*	*	NFP	p2=NNP	2	punct	_
2	Healthcare	healthcare	NNP	p2=NN	0	root	_
3	:	:	:	_	2	punct	_
4	MXN1,044.3bn	mxn1,044.3bn	NNP	_	2	appos	_
5	(	(	-LRB-	_	4	punct	_
6	USD	usd	NNP	p2=NN	7	nn	_
7	81.8bn	81.8bn	NNP	_	4	appos	_
8	)	)	-RRB-	_	4	punct	_
9	in	in	IN	_	2	prep	_
10	2013	0	CD	_	9	pobj	_
11	to	to	IN	p2=TO	2	prep	_
12	MXN1,139.8bn	mxn1,139.8bn	NNP	p2=CD	11	pobj	_
13	(	(	-LRB-	_	2	punct	_
14	USD	usd	NNP	p2=NN	15	nn	_
15	90.8bn	90.8bn	NNP	_	2	appos	_
16	)	)	-RRB-	_	2	punct	_
17	in	in	IN	_	2	prep	_
18	2014	0	CD	_	17	pobj	_
19	;	;	:	p2=,	2	punct	_
20	+9.1	+0	CD	p2=DT	21	num	_
21	%	%	NN	_	2	appos	_
22	in	in	IN	_	21	prep	_
23	local	local	JJ	_	25	amod	_
24	currency	currency	NN	_	25	nn	_
25	terms	term	NNS	_	22	pobj	_
26	and	and	CC	_	21	cc	_
27	+11.0	+0	CD	p2=NN	28	num	_
28	%	%	NN	_	21	conj	_
29	in	in	IN	_	28	prep	_
30	US	us	NNP	_	32	nn	_
31	dollar	dollar	NN	_	32	nn	_
32	terms	term	NNS	_	29	pobj	_
33	.	.	.	_	2	punct	_

1	Forecast	forecast	NNP	p2=VBN	2	nsubj	2:A1=PPT
2	increased	increase	VBD	pb=increase.01	0	root	_
3	from	from	IN	_	2	prep	2:A3=DIR
4	Q214	q214	NNP	_	3	pobj	_
5	due	due	IN	p2=JJ	2	prep	2:AM-CAU
6	to	to	IN	_	5	pcomp	_
7	more	more	RBR	p2=JJR	8	advmod	_
8	optimistic	optimistic	JJ	_	10	amod	_
9	macroeconomic	macroeconomic	JJ	_	10	amod	_
10	forecasts	forecast	NNS	_	5	pobj	_
11	.	.	.	_	2	punct	_

1	Mexico	mexico	NNP	p2=NN	2	nsubj	2:A0=PAG
2	scores	score	VBZ	p2=NNS|pb=score.01	0	root	_
3	60.6	0	CD	_	2	dobj	2:A1=PPT
4	in	in	IN	_	2	prep	2:AM-LOC
5	BMI	bmi	NNP	_	13	poss	_
6	's	's	POS	_	5	possessive	_
7	Pharmaceutical	pharmaceutical	NNP	_	13	nn	_
8	and	and	CC	_	7	cc	_
9	Healthcare	healthcare	NNP	_	7	conj	_
10	Risk	risk	NNP	p2=NN	13	nn	_
11	/	/	SYM	p2=,	10	punct	_
12	Reward	reward	NNP	p2=VB	13	nn	_
13	Rating	rating	NNP	_	4	pobj	_
14	(	(	-LRB-	_	13	punct	_
15	RRR	rrr	NNP	_	13	appos	_
16	)	)	-RRB-	_	13	punct	_
17	,	,	,	_	2	punct	_
18	making	make	VBG	pb=make.02	2	advcl	2:AM-ADV
19	it	it	PRP	_	24	nsubj	_
20	the	the	DT	_	24	det	_
21	fourth-most	fourth-most	JJ	p2=RBS	24	amod	_
22	attractive	attractive	JJ	_	24	amod	_
23	pharmaceutical	pharmaceutical	JJ	p2=NN	24	amod	_
24	market	market	NN	_	18	ccomp	18:A1=PRD
25	in	in	IN	_	24	prep	_
26	the	the	DT	_	27	det	_
27	region	region	NN	_	25	pobj	_
28	.	.	.	_	2	punct	_

1	*	*	NFP	p2=NNP	14	punct	_
2	Mexico	mexico	NNP	_	5	poss	_
3	's	's	POS	p2=VBZ	2	possessive	_
4	Federal	federal	NNP	_	5	nn	_
5	Commission	commission	NNP	_	14	nsubj	14:A0=PAG
6	for	for	IN	_	5	prep	_
7	Protection	protection	NNP	_	6	pobj	_
8	Against	against	IN	p2=NNP	7	prep	_
9	Health	health	NNP	_	10	nn	_
10	Risks	risks	NNP	p2=NNPS	8	pobj	_
11	(	(	-LRB-	_	12	punct	_
12	COFEPRIS	cofepris	NNP	_	10	appos	_
13	)	)	-RRB-	_	12	punct	_
14	signed	sign	VBD	pb=sign.02	0	root	_
15	an	an	DT	_	16	det	_
16	agreement	agreement	NN	_	14	dobj	14:A1=PPT
17	to	to	TO	_	18	aux	_
18	promote	promote	VB	pb=promote.02	16	infmod	_
19	innovation	innovation	NN	_	18	dobj	18:A1=PPT
20	,	,	,	_	19	punct	_
21	under	under	IN	_	32	prep	32:R-AM-LOC
22	which	which	WDT	_	21	pobj	_
23	the	the	DT	_	26	det	_
24	registration	registration	NN	_	25	nn	_
25	approval	approval	NN	_	26	nn	_
26	timeline	timeline	NN	_	32	nsubjpass	32:A1=PPT
27	for	for	IN	_	26	prep	_
28	new	new	JJ	_	29	amod	_
29	molecules	molecule	NNS	_	27	pobj	_
30	will	will	MD	_	32	aux	32:AM-MOD
31	be	be	VB	_	32	auxpass	_
32	reduced	reduce	VBN	pb=reduce.01	14	advcl	_
33	to	to	IN	_	32	prep	32:A4=GOL
34	60	0	CD	_	36	num	_
35	working	working	NN	p2=VBG	36	amod	_
36	days	day	NNS	_	33	pobj	_
37	from	from	IN	_	32	prep	32:A3=DIR
38	the	the	DT	_	41	det	_
39	previous	previous	JJ	_	41	amod	_
40	360	0	CD	_	41	num	_
41	days	day	NNS	_	37	pobj	_
42	.	.	.	_	14	punct	_

1	*	*	NFP	p2=VBD	3	punct	_
2	COFEPRIS	cofepris	NNP	p2=NN	3	nsubj	3:A0=PAG
3	changed	change	VBD	pb=change.01	0	root	_
4	its	its	PRP$	_	7	poss	_
5	clinical	clinical	JJ	_	7	amod	_
6	research	research	NN	_	7	nn	_
7	protocol	protocol	NN	_	3	dobj	3:A1=PPT
8	to	to	TO	_	9	aux	_
9	reduce	reduce	VB	pb=reduce.01	3	advcl	3:AM-PRP
10	the	the	DT	_	12	det	_
11	pre-approval	pre-approval	JJ	_	12	amod	_
12	time	time	NN	_	9	dobj	9:A1=PPT
13	for	for	IN	_	12	prep	_
14	clinical	clinical	JJ	_	15	amod	_
15	trials	trial	NNS	_	13	pobj	_
16	from	from	IN	_	9	prep	9:A3=DIR
17	three	#crd#	CD	_	18	num	_
18	months	month	NNS	_	16	pobj	_
19	to	to	IN	_	9	prep	9:A4=GOL
20	one	#crd#	CD	_	21	num	_
21	month	month	NN	_	19	pobj	_
22	.	.	.	_	3	punct	_

1	COFEPRIS	cofepris	NNP	p2=NN	4	nsubj	4:A0;18:A0=PAG
2	has	have	VBZ	_	4	aux	_
3	also	also	RB	_	4	advmod	4:AM-DIS
4	authorised	authorise	VBN	pb=authorise.01	0	root	_
5	the	the	DT	_	7	det	_
6	National	national	NNP	_	7	nn	_
7	Institutes	institute	NNPS	_	4	dobj	4:A1
8	of	of	IN	_	7	prep	_
9	Health	health	NNP	_	8	pobj	_
10	,	,	,	_	7	punct	_
11	as	as	RB	_	13	advmod	_
12	well	well	RB	_	13	advmod	_
13	as	as	IN	_	7	cc	_
14	speciality	speciality	NN	p2=JJ	15	nn	_
15	hospitals	hospital	NNS	_	7	conj	_
16	,	,	,	_	4	punct	_
17	to	to	TO	_	18	aux	_
18	assist	assist	VB	pb=assist.01	4	advcl	4:AM-PRP
19	its	its	PRP$	_	23	poss	_
20	clinical	clinical	JJ	_	21	amod	_
21	trial	trial	NN	_	23	nn	_
22	evaluation	evaluation	NN	_	23	nn	_
23	process	process	NN	_	18	dobj	18:A1=GOL
24	.	.	.	_	4	punct	_

1	*	*	NFP	p2=RBR	5	punct	_
2	Indian	indian	JJ	p2=NNP	3	amod	_
3	drugmaker	drugmaker	NN	p2=JJR	4	nn	_
4	Lupin	lupin	NNP	p2=NN	5	nsubj	5:A0
5	revealed	reveal	VBD	pb=reveal.01	0	root	_
6	its	its	PRP$	_	7	poss	_
7	acquisition	acquisition	NN	_	5	dobj	5:A1=PPT
8	of	of	IN	_	7	prep	_
9	a	a	DT	_	13	det	_
10	100	0	CD	_	11	num	_
11	%	%	NN	_	13	nn	_
12	equity	equity	NN	_	13	nn	_
13	stake	stake	NN	_	8	pobj	_
14	in	in	IN	_	13	prep	_
15	Laboratorios	laboratorios	NNP	p2=NNPS	16	nn	_
16	Grin	grin	NNP	_	14	pobj	_
17	(	(	-LRB-	_	16	punct	_
18	Grin	grin	NNP	_	16	appos	_
19	)	)	-RRB-	_	16	punct	_
20	,	,	,	_	16	punct	_
21	a	a	DT	_	25	det	_
22	leading	lead	VBG	p2=JJ|pb=lead.01	25	amod	_
23	Mexican	mexican	JJ	_	25	amod	_
24	pharmaceutical	pharmaceutical	JJ	p2=NN	25	amod	_
25	company	company	NN	_	16	appos	22:A0=PAG;26:A0
26	specialising	specialise	VBG	p2=NN|pb=specialize.01	25	partmod	_
27	in	in	IN	_	26	prep	26:AM-LOC
28	branded	brand	VBN	p2=JJ|pb=brand.01	30	amod	_
29	ophthalmic	ophthalmic	JJ	p2=NN	30	amod	_
30	products	product	NNS	_	27	pobj	28:A1
31	.	.	.	_	5	punct	_

1	*	*	NFP	p2=VBD	3	punct	_
2	Genomma	genomma	NNP	_	3	nsubj	3:A0=PAG
3	acquired	acquire	VBD	pb=acquire.01	0	root	_
4	a	a	DT	_	7	det	_
5	50	0	CD	_	6	num	_
6	%	%	NN	_	7	nn	_
7	interest	interest	NN	_	3	dobj	3:A1=PPT
8	in	in	IN	_	7	prep	_
9	Marzam	marzam	NNP	_	13	nn	_
10	Commercial	commercial	NNP	p2=JJ	13	nn	_
11	and	and	CC	_	10	cc	_
12	Industrial	industrial	NNP	_	10	conj	_
13	Group	group	NNP	_	8	pobj	_
14	for	for	IN	_	7	prep	_
15	MXN600mn	mxn600mn	NNP	_	14	pobj	_
16	(	(	-LRB-	_	15	punct	_
17	USD	usd	NNP	p2=NN	18	nn	_
18	45.15mn	45.15mn	NNP	p2=CD	15	appos	_
19	)	)	-RRB-	_	15	punct	_
20	.	.	.	_	3	punct	_

1	*	*	NFP	p2=IN	12	punct	_
2	Mexico	mexico	NNP	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	secretary	secretary	NN	_	12	nsubj	12:A0=PAG
5	of	of	IN	_	4	prep	_
6	Health	health	NNP	_	5	pobj	_
7	,	,	,	_	4	punct	_
8	Mercedes	mercedes	NNP	_	10	nn	_
9	Juan	juan	NNP	_	10	nn	_
10	Lopez	lopez	NNP	_	4	appos	_
11	,	,	,	_	12	punct	_
12	stated	state	VBD	pb=state.01	0	root	_
13	that	that	IN	_	17	complm	_
14	the	the	DT	_	16	det	_
15	federal	federal	JJ	_	16	amod	_
16	agency	agency	NN	_	17	nsubj	17:A0=PAG;19:A0;27:A0=PAG
17	plans	plan	VBZ	p2=NNS|pb=plan.01	12	ccomp	12:A1=PPT
18	to	to	TO	_	19	aux	_
19	reduce	reduce	VB	pb=reduce.01	17	xcomp	17:A1=PPT
20	out	out	RB	p2=RP	22	hmod	_
21	-	-	HYPH	p2=:	22	hyph	_
22	ofpocket	ofpocket	NN	p2=VB	23	nn	_
23	spending	spending	NN	_	19	dobj	19:A1=PPT
24	on	on	IN	_	23	prep	_
25	healthcare	healthcare	NN	_	24	pobj	_
26	and	and	CC	_	19	cc	_
27	improve	improve	VB	pb=improve.01	19	conj	_
28	the	the	DT	_	29	det	_
29	quality	quality	NN	_	27	dobj	27:A1=PPT
30	of	of	IN	_	29	prep	_
31	service	service	NN	_	30	pobj	_
32	through	through	IN	_	27	prep	27:AM-MNR
33	Seguro	seguro	NNP	_	34	nn	_
34	Popular	popular	NNP	_	32	pobj	_
35	in	in	IN	_	34	prep	_
36	Mexico	mexico	NNP	_	35	pobj	_
37	.	.	.	_	12	punct	_

1	The	the	DT	_	3	det	_
2	Health	health	NNP	p2=NN	3	nn	_
3	secretary	secretary	NN	_	6	nsubj	6:A0=PAG;8:A0=PAG;12:A0=PAG
4	has	have	VBZ	_	6	aux	_
5	also	also	RB	_	6	advmod	6:AM-DIS
6	planned	plan	VBN	pb=plan.01	0	root	_
7	to	to	TO	p2=IN	8	aux	_
8	reform	reform	VB	pb=reform.01	6	xcomp	6:A1=PPT
9	Seguro	seguro	NNP	_	10	nn	_
10	Popular	popular	NNP	_	8	dobj	8:A1=PPT
11	to	to	TO	p2=IN	12	aux	_
12	address	address	VB	pb=address.02	8	advcl	8:AM-PRP
13	issues	issue	NNS	_	12	dobj	12:A1=PPT
14	such	such	JJ	_	15	amod	_
15	as	as	IN	_	13	prep	_
16	the	the	DT	_	19	det	_
17	fragmented	fragmented	JJ	_	19	amod	_
18	healthcare	healthcare	NN	_	19	nn	_
19	system	system	NN	_	15	pobj	_
20	and	and	CC	_	19	cc	_
21	inefficient	inefficient	JJ	_	22	amod	_
22	use	use	NN	_	19	conj	_
23	of	of	IN	_	22	prep	_
24	resources	resource	NNS	_	23	pobj	_
25	in	in	IN	_	22	prep	_
26	Mexico	mexico	NNP	_	25	pobj	_
27	.	.	.	_	6	punct	_

1	Fast	fast	JJ	p2=NNP	3	amod	_
2	Market	market	NNP	p2=NN	3	nn	_
3	Research	research	NNP	_	4	nsubj	4:A1=PPT
4	is	be	VBZ	pb=be.01	0	root	_
5	a	a	DT	_	7	det	_
6	leading	lead	VBG	p2=JJ|pb=lead.01	7	amod	_
7	distributor	distributor	NN	_	4	attr	6:A0=PAG;4:A2=PRD
8	of	of	IN	_	7	prep	_
9	market	market	NN	_	10	nn	_
10	research	research	NN	_	8	pobj	_
11	and	and	CC	_	10	cc	_
12	business	business	NN	_	13	nn	_
13	information	information	NN	_	10	conj	_
14	.	.	.	_	4	punct	_

1	Representing	represent	VBG	pb=represent.01	12	advcl	12:AM-ADV
2	the	the	DT	_	3	det	_
3	world	world	NN	_	7	poss	_
4	's	's	POS	_	3	possessive	_
5	top	top	JJ	_	7	amod	_
6	research	research	NN	_	7	nn	_
7	publishers	publisher	NNS	_	1	dobj	1:A1=PPT
8	and	and	CC	_	7	cc	_
9	analysts	analyst	NNS	_	7	conj	_
10	,	,	,	_	12	punct	_
11	we	we	PRP	_	12	nsubj	1:A0=PAG;12:A0=PAG
12	provide	provide	VBP	pb=provide.01	0	root	_
13	quick	quick	JJ	_	16	amod	_
14	and	and	CC	_	13	cc	_
15	easy	easy	JJ	_	13	conj	_
16	access	access	NN	_	12	dobj	12:A1=PPT
17	to	to	IN	_	16	prep	_
18	the	the	DT	_	21	det	_
19	best	good	JJS	p2=RBS	21	amod	_
20	competitive	competitive	JJ	_	21	amod	_
21	intelligence	intelligence	NN	_	17	pobj	_
22	available	available	JJ	_	21	amod	_
23	.	.	.	_	12	punct	_

1	Our	our	PRP$	_	6	advcl	_
2	unbiased	unbiased	JJ	_	6	advcl	_
3	,	,	,	_	6	punct	_
4	expert	expert	NN	p2=JJ	5	nn	_
5	staff	staff	NN	_	6	nsubj	10:A0=PAG;6:A1=PPT
6	is	be	VBZ	pb=be.01	0	root	_
7	always	always	RB	_	6	advmod	6:AM-TMP
8	available	available	JJ	_	6	acomp	6:A2=PRD
9	to	to	TO	_	10	aux	_
10	help	help	VB	pb=help.01	8	xcomp	_
11	you	you	PRP	_	12	nsubj	12:A0=PAG
12	find	find	VB	pb=find.01	10	ccomp	10:A1=PPT
13	the	the	DT	_	15	det	_
14	right	right	JJ	p2=NN	15	amod	_
15	research	research	NN	_	12	dobj	12:A1=PPT
16	to	to	TO	_	17	aux	_
17	fit	fit	VB	pb=fit.01	12	advcl	_
18	your	your	PRP$	_	19	poss	_
19	requirements	requirement	NNS	_	17	dobj	17:A1=PPT
20	and	and	CC	_	19	cc	_
21	your	your	PRP$	_	22	poss	_
22	budget	budget	NN	_	19	conj	_
23	.	.	.	_	6	punct	_

